NEUROONE MEDICAL TECH批准1拆6反向拆股 将于2026年4月15日生效

美股速递
Apr 14

NEUROONE MEDICAL TECH公司已正式批准实施1拆6的反向股票合并方案。根据美国证券交易委员会披露的文件,此项资本结构调整措施将于2026年4月15日正式生效。

反向拆股计划旨在通过合并已发行普通股来提升每股市场价值。具体方案为每6股现有普通股合并为1股新股,该决议经公司董事会审议通过后已完成监管报备流程。

此次股权整合将影响公司已发行在外的总股本数量,但不会改变股东所持股份的实际总价值。公司表示,此举有利于优化股权结构,符合长期发展战略规划。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10